Advertisement
  • Forward Look

    Cancer Screening: A Dose of Reality

    Q&A with H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

    by Sue Rochman

  • Forward Look

    When Is “Cancer” Not Cancer?

    Does the word “cancer” discourage patients with very early disease from fully considering all their options?

    by Stephen Ornes

  • Forward Look

    The Avastin Roller Coaster

    Ups and downs keep coming for Avastin as studies report on its effects for different cancers.

    by Sue Rochman

  • Forward Look

    Boosting Defenses Against Cancer

    Q&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.

    by Ingfei Chen

  • Forward Look

    Second-Cancer Clues?

    Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.

    by Mitzi Baker

  • Forward Look

    A Burning Question for Smokers

    Is the considerable risk-reduction benefit of CT screening worth the potential downsides?

    by Sue Rochman

  • Forward Look

    Getting Personal

    Health care experts push for care that focuses on the patient.

    by Alanna Kennedy-Gorman

  • Forward Look

    Avastin’s Fate

    Debate goes on as FDA revokes drug's use for breast cancer.

    by Alanna Kennedy-Gorman

  • Staying the Course

    Patients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.

    by Melissa Weber

  • The Birth of a Targeted Therapy

    A serendiptious discovery more than 50 years ago heralded a new age of cancer treatment.

    by Jocelyn Selim